The Gary Null Show - 10.11.22

VIDEOS: Serious Adverse Events & Side Effects: Silence is inexcusable (4:51) Words From Aaron Siri on CDC Data On Covid Vaccines – (1:10 – 2:47) Bill Clinton and Blackrock team up to ACCELERATE the great reset | Redacted with Clayton Morris Neil Oliver – ‘…digital enslavement is coming…’ (4:46-19:06) Tulsi Gabbard leaves Democratic Party, denounces it as ‘elitist cabal’ (0:20 – 2:49)   Resveratrol supplementation linked to better blood lipidsSoutheast University (China), October 10 2022. A meta-analysis of randomized, controlled trials published in the journal Nutrients found an association between lower lipids and supplementing with resveratrol, a nonflavonoid polyphenol compound found in grapes, knotweed and other plants. Researchers at Southeast University in Nanjing, China identified 17 trials that included a total of 968 men and women for their meta-analysis. Resveratrol doses ranged from 10 to 3,000 milligrams per day administered from 4 to 48 weeks. The meta-analysis revealed a significant association between resveratrol supplementation and reductions in total cholesterol, low-density lipoprotein (LDL) cholesterol and triglyceride levels. The reduction in LDL cholesterol associated with resveratrol was significantly greater in trials of at least 12 weeks duration, trials that administered dosages of 500 milligrams resveratrol per day or more and among people with type 2 diabetes. The researchers did not find an association between supplementing with resveratrol and “good” high-density lipoprotein (HDL) cholesterol levels. “This meta-analysis indicated that the supplementation of resveratrol could significantly affect the serum levels of total cholesterol, LDL-cholesterol and triglycerides, but not the level of HDL-cholesterol,” they concluded. “Findings from this meta-analysis could be helpful for providing suggestions for the use of resveratrol as nutraceutical.” A Mulberry Component, Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding DomainKorea Institute of Oriental Medicine, September 28, 2022 Despite the recent development of RNA replication-targeted COVID-19 drugs by global pharmaceutical companies, their prescription in clinical practice is limited by certain factors, including drug interaction, reproductive toxicity, and drug resistance. Natural products are a potential source of molecules with therapeutic effects against COVID-19. In this study, we investigated the inhibitory efficacy of mulberrofuran G (MG), a component of mulberry, which has been used as food and traditional medicine, on the binding of the spike S1 receptor-binding domain (RBD) protein to the angiotensin-converting enzyme 2 (ACE2) receptor, which is the initial stage of the SARS-CoV-2 infection. In competitive enzyme-linked immunosorbent assays, MG effectively blocked the spike S1 RBD: ACE2 receptor molecular binding, and investigations using the BLItz system and in silico modeling revealed that MG has high affinity for both proteins. Finally, we confirmed that MG inhibits the entry of SARS-CoV-2 spike pseudotyped virus and a clinical isolate of SARS-CoV-2 into cells, suggesting that MG might be a promising therapeutic candidate for preventing SARS-CoV-2 binding to the cell surface during early infection. Positive childhood experiences of blue spaces linked to better adult well-beingSapienza University (Italy) & University of Exeter (UK), October 10, 2022New research based on data from 18 countries concludes that adults with better mental health are more likely to report having spent time playing in and around coastal and inland waters, such as rivers and lakes (also known collectively as blue spaces) as children. The finding was replicated in each of the countries studied. Mounting evidence shows that spending time in and around green spaces such as parks and woodlands in adulthood is associated with stress reduction and better mental health. However, we know far less ab